Mikrobiomik is a bio-pharmaceutical company founded to conduct research into and develop medicines based on the human microbiome.
Our vision
We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure.
Our values
Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic solutions based on the human microbiome through excellence in its processes, empathising with chronic patients for whom no curative treatments are available, always from the perspective of networking with all stakeholders in the sector.
Our vision
We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure.
Our values
Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic solutions based on the human microbiome through excellence in its processes, empathising with chronic patients for whom no curative treatments are available, always from the perspective of networking with all stakeholders in the sector.
Location: Spain, Autonomous Community of the Basque Country, Derio
Employees: 1-10
Investors 1
| Date | Name | Website |
| - | Orza Inves... | orza.info |
Mentions in press and media 2
| Date | Title | Description |
| 29.09.2023 | Mikrobiomik, apoyada por Orza y Seed Capital Bizkaia, cierra una ampliación de capital por valor de 1.1 M€ | 29/09/2023 Nota de prensa MIKROBIOMIK, APOYADA POR ORZA Y SEED CAPITAL BIZKAIA, CIERRA UNA AMPLIACIÓN DE CAPITAL POR VALOR DE 1.1 M€ En un gran paso hacia la evolución de la investigación médica, Mikrobiomik, la empresa pionera en el mic... |
| 03.12.2021 | Seed Capital Bizkaia invierte €657.000 en 4 proyectos empresariales | 03/12/2021 Nota de prensa SEED CAPITAL BIZKAIA INVIERTE €657.000 EN 4 PROYECTOS EMPRESARIALES. Seed Capital Bizkaia trabaja desde hace más de 30 años por el fomento de la innovación, el impacto social y la promoción y regeneración del te... |